Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Preexposure prophylaxis for the prevention of HIV transmission to women.

Aaron E, Cohan D.

AIDS. 2013 Jan 2;27(1):F1-5. doi: 10.1097/QAD.0b013e32835917b4.

PMID:
22914582
2.
3.

Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.

Li J, Dufrene SL, Okulicz JF.

Ann Pharmacother. 2014 Apr;48(4):507-18. doi: 10.1177/1060028014520880. Epub 2014 Jan 28. Review.

PMID:
24473492
4.

Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.

Myers GM, Mayer KH.

AIDS Patient Care STDS. 2011 Feb;25(2):63-71. doi: 10.1089/apc.2010.0222. Review.

PMID:
21284497
5.

Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

Baeten JM, Haberer JE, Liu AY, Sista N.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9. doi: 10.1097/QAI.0b013e3182986f69. Review.

6.

Use of antiretrovirals for HIV prevention: what do we know and what don't we know?

Baeten JM, Grant R.

Curr HIV/AIDS Rep. 2013 Jun;10(2):142-51. doi: 10.1007/s11904-013-0157-9. Review.

7.

Oral antiretroviral chemoprophylaxis: current status.

Baeten J, Celum C.

Curr Opin HIV AIDS. 2012 Nov;7(6):514-9. doi: 10.1097/COH.0b013e3283582d30. Review.

8.

[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].

Boot J, Rump BO, Boucher CA, Op de Coul EL, van Agtmael MA, van de Vijver DA, Burger DM, Fanoy EB.

Ned Tijdschr Geneeskd. 2013;157(27):A6063. Review. Dutch.

PMID:
23838402
9.

Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence.

Celum C, Baeten JM.

Curr Opin Infect Dis. 2012 Feb;25(1):51-7. doi: 10.1097/QCO.0b013e32834ef5ef. Review.

10.

Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.

McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE.

AIDS Patient Care STDS. 2014 Sep;28(9):462-74. doi: 10.1089/apc.2013.0302. Epub 2014 Jul 21. Review.

11.

Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.

Schackman BR, Eggman AA.

Curr Opin HIV AIDS. 2012 Nov;7(6):587-92. doi: 10.1097/COH.0b013e3283582c8b. Review.

PMID:
23076124
12.

[HIV preexposure prophylaxis].

Olczak A, Grabczewska E.

Przegl Epidemiol. 2012;66(1):79-82. Review. Polish.

13.

Considerations regarding antiretroviral chemoprophylaxis in MSM.

Poynten IM, Zablotska I, Grulich AE.

Curr Opin HIV AIDS. 2012 Nov;7(6):549-56. doi: 10.1097/COH.0b013e3283582c71. Review.

PMID:
22918448
14.

Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.

Nadery S, Geerlings SE.

Neth J Med. 2013 Jul-Aug;71(6):295-9. Review.

15.

Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?

Verguet S, Stalcup M, Walsh JA.

Sex Transm Infect. 2013 Dec;89(8):628-34. doi: 10.1136/sextrans-2012-050891. Epub 2013 Aug 2. Review.

PMID:
23912819
16.

The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.

van de Vijver DA, Boucher CA.

Curr Opin Infect Dis. 2010 Dec;23(6):621-7. doi: 10.1097/QCO.0b013e32833ff1e6. Review.

PMID:
20847692
17.

Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.

Blackwell CW.

Nurse Pract. 2014 Sep 18;39(9):50-3. doi: 10.1097/01.NPR.0000452976.92052.fa. Review.

PMID:
25140852
18.

Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.

Amico KR.

Curr Opin HIV AIDS. 2012 Nov;7(6):542-8. doi: 10.1097/COH.0b013e3283582d4a. Review.

PMID:
22964887
19.

Systemic preexposure prophylaxis for human immunodeficiency virus infection.

Romanelli F, Murphy B.

Pharmacotherapy. 2010 Oct;30(10):1021-30. doi: 10.1592/phco.30.10.1021. Review.

PMID:
20874040
20.

Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.

Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R.

Curr Opin HIV AIDS. 2016 Jan;11(1):18-26. doi: 10.1097/COH.0000000000000207. Review.

Supplemental Content

Support Center